| abstract |
The invention relates to stem cells with enhanced clonogenic, migratory and homing capacities and a method of obtaining said stem cells comprising co-culturing said stem cells in contact with at least a resting or activated NK cell. Also relates to compounds and compositions comprising said stem cells and their use for the treatment of diseases that may benefit from tissue regeneration, bone marrow transplantation and wound healing. |